T1	Concept 0 5;18 23;24 34;6 17	Lower tract infections respiratory
T2	Concept 36 40	LRTI
*	same-as T1 T2
T3	Action 67 82	hospitalization
T4	Action 87 96	mortality
T5	Concept 140 150	recipients
T6	Concept 100 113;114 122;123 133	hematopoietic cellular transplant
T7	Concept 135 138	HCT
*	same-as T6 T7
R1	in-context Arg1:T5 Arg2:T7	
R2	target Arg1:T4 Arg2:T5	
T8	Concept 140 150	recipients
R3	in-context Arg1:T8 Arg2:T7	
R4	target Arg1:T3 Arg2:T8	
R5	subject Arg1:T3 Arg2:T2	
R6	subject Arg1:T4 Arg2:T2	
A1	Emphasized T3
A2	Emphasized T4
T9	Concept 172 175	HCT
T10	Concept 176 186	recipients
R7	in-context Arg1:T10 Arg2:T9	
T11	Concept 164 168	LRTI
T12	Concept 151 160	Diagnosis
R8	in-context Arg1:T12 Arg2:T11	
R9	in-context Arg1:T12 Arg2:T10	
T13	Concept 203 214	challenging
A3	Emphasized T13
R10	has-property Arg1:T12 Arg2:T13	
T14	Concept 371 376;377 386	mimic infection
T15	Concept 361 366	fever
T16	Concept 330 339;340 352	pulmonary inflammation
T17	Concept 236 249;250 262;263 273	noninfectious inflammatory conditions
T18	Concept 282 287;288 294;295 299;300 307	graft versus host disease
T19	Concept 309 313	GVHD
*	same-as T18 T19
R11	is-a Arg1:T18 Arg2:T17	
T20	Concept 222 232	high rates
R12	in-context Arg1:T20 Arg2:T17	
R13	causes Arg1:T20 Arg2:T13	
R14	causes Arg1:T18 Arg2:T16	
R15	causes Arg1:T18 Arg2:T15	
R16	causes Arg1:T18 Arg2:T14	
T21	Concept 387 398;399 403;404 414;415 425	Metagenomic next generation sequencing
T22	Concept 427 431	mNGS
*	same-as T21 T22
T23	Concept 460 470	diagnostic
T24	Concept 451 459	enhanced
R17	has-property Arg1:T23 Arg2:T24	
R18	entails Arg1:T22 Arg2:T23	
T25	Action 487 496	providing
T26	Concept 499 506;507 518	culture independent
T27	Concept 520 533	comprehensive
T28	Action 534 545	measurement
R19	subject Arg1:T25 Arg2:T22	
R20	target Arg1:T25 Arg2:T28	
R21	in-context Arg1:T28 Arg2:T26	
R22	in-context Arg1:T28 Arg2:T27	
T29	Concept 553 562;563 574	microbial composition
R23	target Arg1:T28 Arg2:T29	
T30	Concept 578 586;587 594	clinical samples
R24	has-part Arg1:T30 Arg2:T29	
T31	Reference 595 599	This
T32	Concept 600 610	technology
R25	is-a Arg1:T31 Arg2:T32	
T33	Action 636 645	detection
T34	Concept 623 635	simultaneous
R26	in-context Arg1:T33 Arg2:T34	
T35	Concept 649 658	bacterial
T36	Concept 660 665	viral
T37	Concept 670 676	fungal
T38	Concept 677 686	pathogens
R27	target Arg1:T33 Arg2:T35	
R28	target Arg1:T33 Arg2:T36	
R29	target Arg1:T33 Arg2:T37	
R30	is-a Arg1:T35 Arg2:T38	
R31	is-a Arg1:T36 Arg2:T38	
R32	is-a Arg1:T37 Arg2:T38	
T39	Action 695 706	introducing
T40	Concept 707 711	bias
A4	Negated T39
T41	Concept 728 740;741 744	fixed-target PCR
T42	Concept 748 757	serologic
R33	causes Arg1:T41 Arg2:T40	
R34	causes Arg1:T42 Arg2:T40	
R35	target Arg1:T39 Arg2:T40	
T43	Action 611 618	permits
R36	target Arg1:T43 Arg2:T33	
R37	subject Arg1:T43 Arg2:T31	
R38	subject Arg1:T39 Arg2:T31	
T44	Concept 799 810;811 817	multi-organ damage
T45	Concept 799 810;822 833	multi-organ dysfunction
T46	Concept 783 791	patients
T47	Concept 767 768;769 779	a proportion
R39	in-context Arg1:T46 Arg2:T47	
T48	Action 792 798	showed
A5	Uncertain T48
R40	subject Arg1:T48 Arg2:T46	
R41	target Arg1:T48 Arg2:T44	
R42	target Arg1:T48 Arg2:T45	
